Home - Products - Microbiology/Virology - Influenza Virus - Influenza A NP(366-374) Strain A/PR/8/35

Influenza A NP(366-374) Strain A/PR/8/35

CAS No. 132326-73-9

Influenza A NP(366-374) Strain A/PR/8/35( —— )

Catalog No. M30343 CAS No. 132326-73-9

This peptide is an H2-Db-restricted epitope from the Influenza A/PR/8/34 nucleoprotein.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    Influenza A NP(366-374) Strain A/PR/8/35
  • Note
    Research use only, not for human use.
  • Brief Description
    This peptide is an H2-Db-restricted epitope from the Influenza A/PR/8/34 nucleoprotein.
  • Description
    This peptide is an H2-Db-restricted epitope from the Influenza A/PR/8/34 nucleoprotein.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Influenza Virus
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132326-73-9
  • Formula Weight
    1026.1
  • Molecular Formula
    C38H63N11O18S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Ala}{Ser}{Asn}{Glu}{Asn}{Met}{Glu}{Thr}{Met}

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Traboulsi H, et al. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection. Antimicrob Agents Chemother. 2015 Oct;59(10):6317-27.
molnova catalog
related products
  • Nucleozin

    A small-molecule influenza A nucleoprotein (NP) inhibitor that triggers the aggregation of NP and inhibits its nuclear accumulation.

  • Sodium copper chloro...

    Sodium copper chlorophyllin B exerts antiviral activities against Influenza virus and HIV.

  • NS1-IN-1

    NS1-IN-1 is a potent NS1 inhibitor.NS1-IN-1 displays antiviral activity by inhibiting mTORC1 activity in a TSC1-TSC2-dependent manner.